Search

Garen Gotfredson

Examiner (ID: 3455, Phone: (571)270-3468 , Office: P/1619 )

Most Active Art Unit
1619
Art Unit(s)
1619
Total Applications
667
Issued Applications
237
Pending Applications
89
Abandoned Applications
352

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18389826 [patent_doc_number] => 20230158044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => MONOLITHIC INTRAVAGINAL RINGS COMPRISING PROGESTERONE AND METHODS OF MAKING AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/857959 [patent_app_country] => US [patent_app_date] => 2022-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13197 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17857959 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/857959
MONOLITHIC INTRAVAGINAL RINGS COMPRISING PROGESTERONE AND METHODS OF MAKING AND USES THEREOF Jul 4, 2022 Abandoned
Array ( [id] => 19387775 [patent_doc_number] => 20240277645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => CONTINOUS IMPREGNATION OF ACTIVE PHARMACEUTICAL INGREDIENTS ONTO POROUS CARRIERS [patent_app_type] => utility [patent_app_number] => 18/571083 [patent_app_country] => US [patent_app_date] => 2022-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11171 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18571083 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/571083
CONTINOUS IMPREGNATION OF ACTIVE PHARMACEUTICAL INGREDIENTS ONTO POROUS CARRIERS Jun 12, 2022 Pending
Array ( [id] => 17865225 [patent_doc_number] => 20220287960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => SUSTAINED RELEASE ESTROGEN VAGINAL RING PESSARY FOR TREATMENT OF ATROPHY, CYSTITIS AND UTEROVAGINAL PROLAPSE [patent_app_type] => utility [patent_app_number] => 17/829702 [patent_app_country] => US [patent_app_date] => 2022-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6489 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17829702 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/829702
Sustained release estrogen vaginal ring pessary for treatment of atrophy, cystitis and uterovaginal prolapse May 31, 2022 Issued
Array ( [id] => 19297829 [patent_doc_number] => 20240226395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-11 [patent_title] => COATING FOR MEDICAL DEVICES [patent_app_type] => utility [patent_app_number] => 18/563331 [patent_app_country] => US [patent_app_date] => 2022-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11076 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563331 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/563331
COATING FOR MEDICAL DEVICES May 29, 2022 Pending
Array ( [id] => 19246614 [patent_doc_number] => 20240197598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => AMINO ACID SCALP AND HAIR CARE COMPOSITION, SCALP AND HAIR CARE PRODUCT CONTAINING SAID COMPOSITION AND PREPARATION METHOD [patent_app_type] => utility [patent_app_number] => 18/574435 [patent_app_country] => US [patent_app_date] => 2022-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2530 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18574435 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/574435
AMINO ACID SCALP AND HAIR CARE COMPOSITION, SCALP AND HAIR CARE PRODUCT CONTAINING SAID COMPOSITION AND PREPARATION METHOD May 29, 2022 Pending
Array ( [id] => 17850597 [patent_doc_number] => 20220280638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => METHODS AND ARTICLES FOR ALLERGIC DESENSITIZATION VIA THE ORAL MUCOSA [patent_app_type] => utility [patent_app_number] => 17/740878 [patent_app_country] => US [patent_app_date] => 2022-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17527 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17740878 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/740878
METHODS AND ARTICLES FOR ALLERGIC DESENSITIZATION VIA THE ORAL MUCOSA May 9, 2022 Abandoned
Array ( [id] => 19297455 [patent_doc_number] => 20240226020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-11 [patent_title] => SOTORASIB FORMULATION [patent_app_type] => utility [patent_app_number] => 18/558827 [patent_app_country] => US [patent_app_date] => 2022-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21218 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -83 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18558827 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/558827
SOTORASIB FORMULATION May 4, 2022 Pending
Array ( [id] => 17928408 [patent_doc_number] => 20220323533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => COMPOSITION FOR PREVENTING, INHIBITING OR TREATING INFECTION OF CORONAVIRUS [patent_app_type] => utility [patent_app_number] => 17/714769 [patent_app_country] => US [patent_app_date] => 2022-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3804 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714769 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/714769
COMPOSITION FOR PREVENTING, INHIBITING OR TREATING INFECTION OF CORONAVIRUS Apr 5, 2022 Abandoned
Array ( [id] => 17733412 [patent_doc_number] => 20220218871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => MEDICAL DEVICE WITH A BIOCOMPATIBLE COATING [patent_app_type] => utility [patent_app_number] => 17/710491 [patent_app_country] => US [patent_app_date] => 2022-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3902 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17710491 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/710491
MEDICAL DEVICE WITH A BIOCOMPATIBLE COATING Mar 30, 2022 Abandoned
Array ( [id] => 17911216 [patent_doc_number] => 20220313611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => METHODS TO PREPARE DRY POWDERS USING SUSPENSION BASED THIN FILM FREEZING [patent_app_type] => utility [patent_app_number] => 17/693062 [patent_app_country] => US [patent_app_date] => 2022-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28556 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17693062 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/693062
METHODS TO PREPARE DRY POWDERS USING SUSPENSION BASED THIN FILM FREEZING Mar 10, 2022 Pending
Array ( [id] => 19324705 [patent_doc_number] => 12042357 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-23 [patent_title] => Bellows bandage drug delivery system [patent_app_type] => utility [patent_app_number] => 17/691897 [patent_app_country] => US [patent_app_date] => 2022-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 861 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691897 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/691897
Bellows bandage drug delivery system Mar 9, 2022 Issued
Array ( [id] => 17981121 [patent_doc_number] => 20220347157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-03 [patent_title] => SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING (1R, 5S)-1-(NAPHTHALEN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE [patent_app_type] => utility [patent_app_number] => 17/691911 [patent_app_country] => US [patent_app_date] => 2022-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4917 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691911 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/691911
SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING (1R, 5S)-1-(NAPHTHALEN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE Mar 9, 2022 Abandoned
Array ( [id] => 20700307 [patent_doc_number] => 12622998 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-05-12 [patent_title] => Liquid dressing [patent_app_type] => utility [patent_app_number] => 17/691660 [patent_app_country] => US [patent_app_date] => 2022-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 0 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691660 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/691660
Liquid dressing Mar 9, 2022 Issued
Array ( [id] => 19535532 [patent_doc_number] => 12128065 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-29 [patent_title] => Composition and methods for generating and sustaining molecular hydrogen (H [patent_app_type] => utility [patent_app_number] => 17/685644 [patent_app_country] => US [patent_app_date] => 2022-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 32615 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17685644 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/685644
Composition and methods for generating and sustaining molecular hydrogen (H Mar 2, 2022 Issued
Array ( [id] => 17828601 [patent_doc_number] => 20220265905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => Polyurethane Based Medical Articles [patent_app_type] => utility [patent_app_number] => 17/680657 [patent_app_country] => US [patent_app_date] => 2022-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13535 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17680657 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/680657
Polyurethane based medical articles Feb 24, 2022 Issued
Array ( [id] => 18374234 [patent_doc_number] => 20230149311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => PHARMACEUTICAL COMPOSITION OF LIPID NANOPARTICLE FOR DELIVERING NUCLEIC ACID DRUG CONTAINING TREHALOSE DERIVATIVE AND NOVEL STRUCTURE-MAINTAINING LIPID COMPOUND [patent_app_type] => utility [patent_app_number] => 17/676822 [patent_app_country] => US [patent_app_date] => 2022-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7188 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17676822 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/676822
Pharmaceutical composition of lipid nanoparticle for delivering nucleic acid drug containing trehalose derivative and novel structure-maintaining lipid compound Feb 21, 2022 Issued
Array ( [id] => 19096265 [patent_doc_number] => 20240115492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => AN ORODISPERSIBLE PHARMACEUTICAL SOLID DOSAGE FORM OF RASAGILINE [patent_app_type] => utility [patent_app_number] => 18/262867 [patent_app_country] => US [patent_app_date] => 2022-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27312 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 282 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18262867 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/262867
AN ORODISPERSIBLE PHARMACEUTICAL SOLID DOSAGE FORM OF RASAGILINE Jan 27, 2022 Pending
Array ( [id] => 20218482 [patent_doc_number] => 20250281413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-11 [patent_title] => PHARMACEUTICAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/261523 [patent_app_country] => US [patent_app_date] => 2022-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25158 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -51 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261523 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/261523
PHARMACEUTICAL COMPOSITION Jan 23, 2022 Pending
Array ( [id] => 17593354 [patent_doc_number] => 20220142927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS [patent_app_type] => utility [patent_app_number] => 17/580991 [patent_app_country] => US [patent_app_date] => 2022-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38245 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17580991 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/580991
TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS Jan 20, 2022 Abandoned
Array ( [id] => 17748024 [patent_doc_number] => 20220226227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => DISSOLVABLE SOLID ARTICLE CONTAINING PRESERVATIVES [patent_app_type] => utility [patent_app_number] => 17/580180 [patent_app_country] => US [patent_app_date] => 2022-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10876 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 283 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17580180 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/580180
Dissolvable solid article containing preservatives Jan 19, 2022 Issued
Menu